⌘K

Login Start Free

Home/Filings/4/0001209191-22-003708

4//SEC Filing

ASELAGE STEVE 4

Accession 0001209191-22-003708

CIK 0001069308other

View on SEC.gov Company Profile

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 4:15 PM ET

Size

5.5 KB

Accession

0001209191-22-003708

Insider Transaction Report

Form 4

Period: 2022-01-14

Acer Therapeutics Inc.ACER

Director

Transactions

Award
Stock Option (right to buy)
2022-01-14+18,500→ 18,500 total
Exercise: $2.21Exp: 2032-01-14→ Common Stock (18,500 underlying)

Footnotes (1)

[F1]The option vests and becomes exercisable in full on January 14, 2023.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Acer Therapeutics Inc.

CIK 0001069308

Entity typeother

Related Parties

1

filerCIK 0001221599

Filing Metadata

Form type: 4
Filed: Jan 18, 7:00 PM ET
Accepted: Jan 19, 4:15 PM ET
Size: 5.5 KB

View on SEC.gov